NOVOZYMES A/S SPONS.ADR 1 (NZM) — Net Asset Quality Index
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Net Asset Quality Index of 66.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €16.52 Billion minus total liabilities of €5.60 Billion yields net assets of €10.92 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read NOVOZYMES A/S SPONS.ADR 1 (NZM) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
NOVOZYMES A/S SPONS.ADR 1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how NOVOZYMES A/S SPONS.ADR 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 66.1%, representing net assets of €10.92 Billion against total assets of €16.52 Billion EUR. For live market cap and overall valuation, see NZM market cap.
Annual Net Asset Quality Index for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See NOVOZYMES A/S SPONS.ADR 1 (NZM) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.4% | €10.86 Billion | €16.35 Billion | €5.49 Billion | ▼ -7.2 pp |
| 2024 | 73.5% | €11.18 Billion | €15.20 Billion | €4.02 Billion | ▲ +23.0 pp |
| 2023 | 50.5% | €1.93 Billion | €3.81 Billion | €1.88 Billion | ▼ -0.3 pp |
| 2022 | 50.8% | €1.91 Billion | €3.76 Billion | €1.85 Billion | ▲ +1.6 pp |
| 2021 | 49.3% | €1.64 Billion | €3.33 Billion | €1.69 Billion | — |